Planta Med 2001; 67(5): 417-422
DOI: 10.1055/s-2001-15816
Original Paper
Pharmacology
© Georg Thieme Verlag Stuttgart · New York

Effects of Ginsenosides from Panax ginseng on Cell-to-Cell Communication Function Mediated by Gap Junctions

You-Wei Zhang1,2,*, De-Qiang Dou1 , Lei Zhang1 , Yin-Jie Chen1 , Xin-Sheng Yao1
  • 1 Division of Natural Products Chemistry, Shen Yang Pharmaceutical University, Shen Yang, China
  • 2 Present address: Department of Physiological Chemistry, Tokyo Medical & Dental University, Tokyo, Japan
Further Information

Publication History

July 24, 2000

October 25, 2000

Publication Date:
31 December 2001 (online)

Preview

Abstract

Gap junctions have been shown or are believed to be involved in the pathogenesis of many inherited and acquired human diseases. Agents that regulate the gap junction-mediated intercellular communication (GJIC) function may facilitate prevention and treatment of GJIC-involved diseases. In the present study we examined the effects of 27 ginsenosides isolated from Panax ginseng on GJIC. The results show that compounds 1 (oleanolic acid), 2 (ginsenoside-R0), 3 (ginsenoside-Rb1), 5 (ginsenoside-Rb2), 7 (ginsenoside-Rd), 8 (ginsenoside-Rg3), 12 (panaxadial), 13 (notoginsenoside-R4), 17 [ginsenoside-Rg2 (20S)], 18 (ginsenoside-Rf), and 26 (ginsenoside-F3) did not obviously affect GJIC, whereas compounds 4 (ginsenoside-Rc), 6 (ginsenoside-Rb3), 9 (ginsenoside-Rd2), 10 (notoginsenoside-Fe), 11 (ginsenoside-Rh2), 14 (ginsenoside-Ra1), 15 (ginsenoside-Re), 16 [ginsenoside-Rg2 (20R)], 19 (ginsenoside-Ia), 20 [ginsenoside-Rh1 (20S)], 21 [ginsenoside-Rh1 (20R)], 22 (ginsenoside-F1), 23 (protopanaxatriol), 24 (panaxatriol), 25 (ginsenoside-Rg1), and 27 (chikusetsaponin-L8) induced GJIC reductions at various degrees. Compounds 2, 7, and 8 protected against the tyrosine phosphatase inhibitor vanadate-induced GJIC reduction, while compounds 1, 5, 7, and 17 inhibited the cytokine interleukin 1 alpha (IL-1α)-induced reduction in GJIC. Nevertheless, no compounds protected against the protein kinase C (PKC) activator 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced GJIC inhibition. On the other hand, GJIC reductions induced by compounds 6, 9, 10, 20, 21, 22, 24, and 25 were inhibited by the tyrosine kinase (TK) inhibitor genistein, while GJIC reductions induced by compounds 6, 9, 14, 16, 19, 21, and 24 were attenuated in the presence of the PKC inhibitor calphostin C. However, GJIC reductions induced by compounds 4, 23, and 27 were not inhibited either by genistein or by calphostin C. These data indicate that various mechanisms are responsible for effects of ginsenosides on GJIC.

References

Dr You-Wei Zhang

Room 201

Masakikoupu

4-2-12 Kita-Koiwa

Edogawa Ku

133-0051 Tokyo

Japan

Email: zywlcell@yahoo.com

Phone: Tel. and Fax: +81-3-5694-4940